Gupta, Vikas A.
Emory University · Winship Cancer Institute
7 papers on CoChatORCID 0000-0002-8980-2338
Most cited papers
- Verified
Impact of primary molecular cytogenetic abnormalities and risk of progression in smoldering multiple myeloma
Rajkumar, S. V., Gupta, V, Fonseca, R., Dispenzieri, A., Gonsalves, W. I., Larson, D., Ketterling, R. P., Lust, J. A., Kyle, R. A., & Kumar, S. K. (2013) · Leukemia
Multiple Myeloma Research and TreatmentsChronic Lymphocytic Leukemia Research
Cited by 239
- Verified
Long-Term Follow-Up Results of Lenalidomide, Bortezomib, and Dexamethasone Induction Therapy and Risk-Adapted Maintenance Approach in Newly Diagnosed Multiple Myeloma
Joseph, N. S., Kaufman, J. L., Dhodapkar, M. V., Hofmeister, C. C., Almaula, D. K., Heffner, L. T., Gupta, V. A., Boise, L. H., Lonial, S., & Nooka, A. K. (2020) · Journal of Clinical Oncology
Multiple Myeloma Research and TreatmentsBone health and treatments
Cited by 238
- Verified
Bone marrow microenvironment–derived signals induce Mcl-1 dependence in multiple myeloma
Gupta, V. A., Matulis, S. M., Conage-Pough, J. E., Nooka, A. K., Kaufman, J. L., Lonial, S., & Boise, L. H. (2017) · Blood
Multiple Myeloma Research and TreatmentsCell death mechanisms and regulation
Cited by 113
- Verified
Prophylactic tocilizumab to prevent cytokine release syndrome (CRS) with teclistamab: A single-center experience
Scott, S. A., Marin, E. M., Maples, K. T., Joseph, N. S., Hofmeister, C. C., Gupta, V. A., Dhodapkar, M. V., Kaufman, J. L., Lonial, S., & Nooka, A. K. (2023) · Blood Cancer Journal
Multiple Myeloma Research and TreatmentsMonoclonal and Polyclonal Antibodies Research
Cited by 63
- Verified
Regulation of antigen-specific T cell infiltration and spatial architecture in multiple myeloma and premalignancy
Robinson, M. H., Villa, N. Y., Jaye, D. L., Nooka, A. K., Duffy, A., McCachren, S. S., Manalo, J., Switchenko, J. M., Barnes, S., Potdar, S., et al. (2023) · Journal of Clinical Investigation
Multiple Myeloma Research and TreatmentsCancer Immunotherapy and Biomarkers
Cited by 48
- Verified
Risk of Infections in Multiple Myeloma Patients Treated with Bispecific Antibodies
Cani, L., Scott, S. A., Joseph, N. S., Hofmeister, C. C., Gupta, V. A., Dhodapkar, M. V., Lonial, S., Nooka, A. K., & Kaufman, J. L. (2024) · Blood
Multiple Myeloma Research and TreatmentsMonoclonal and Polyclonal Antibodies Research
Cited by 9
- Verified
Immune-aging is linked to clinical malignancy, racial ancestry, and vaccine responses in myeloma
Potdar, S. V., Kapadia, S., Azeem, M. I., Radzievski, R., Lakhani, K., Joseph, N. S., Kaufman, J. L., Hofmeister, C. C., Gupta, V. A., Lonial, S., et al. (2025) · Blood Advances
Multiple Myeloma Research and TreatmentsT-cell and B-cell Immunology
Cited by 7
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free